Samsung Life Insurance has secured its 100th registered patent for a system that allows customers to check their eligibility for insurance enrollment in advance.
The company announced on September 8 that it has completed the patent registration for the 'Expected Underwriting Result System.'
This system is designed to enable customers to verify their eligibility before undergoing the underwriting process for insurance enrollment.
Previously, customers had to complete their insurance application and input their medical history before receiving the final eligibility results. If the underwriting results indicated a denial, customers would need to restart the application process to find alternative products.
To address this issue, Samsung Life developed a system that allows customers to check the expected underwriting results for currently available products in real time, based solely on their selections. The company filed for the patent in 2022. With customer consent, relevant data is transmitted from the Korea Credit Information Corporation through an encrypted channel, applying Samsung Life's own underwriting criteria. If a specific product is likely to be denied, the system also suggests alternative products or conditions.
A Samsung Life representative stated, "The core of this patent is improving the underwriting process so that customers can quickly verify their eligibility and receive suitable product recommendations. We will continue to expand services that enhance customer convenience throughout the entire process, from insurance design to claims payment."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.
